Lee Chan Henry sold $110K of ONC
Lee Chan Henry (SVP, General Counsel) sold 428 shares of BeOne Medicines Ltd. (ONC) at $257.64 ($0.11M total) on 2026-06-11.
How this was made
The 30-second read
Why it matters
This provides a fresh, primary-source datapoint on insider selling activity, but it does not include guidance, trial results, regulatory actions, or deal terms that would typically drive repricing.
Market read
Traders may monitor for follow-on insider activity, but the disclosure alone is unlikely to be a major driver of ONC price.
What to watch
The filing shows holdings after transaction are 0 shares, but it does not provide reasons for sale or any concurrent corporate/clinical developments.
Background
The article is an SEC EDGAR Form 4 insider transaction disclosure for BeOne Medicines Ltd. (ONC).
Ticker impact
SEC Form 4 shows ONC SVP General Counsel Lee Chan Henry sold 428 shares in an open-market transaction on 2026-06-11.
Likely limited near-term impact; any effect should be small and sentiment-driven.
The filing is a Form 4 insider transaction (428 shares, ~$110k) without disclosed company-specific operational or financial news.
Market effects
No sector read-through; this is company-specific insider transaction data only.
None indicated.
None indicated.
Counterpoint
Insider sales are often planned for diversification or liquidity; the absence of a stated 10b5-1 plan does not necessarily imply negative fundamentals.
Key entities
- issuerBeOne Medicines Ltd.
Company whose insider transaction is disclosed on SEC Form 4.
- insiderLee Chan Henry
SVP, General Counsel who reported the open-market sale.
